Degenerate Capital
Welcome to Degenerate Capital, where two amateur investors dive headfirst into the stock market without pretending to be Wall Street pros. We’re here to prove that you don’t need an MBA or a Bloomberg terminal to make smart moves—you just need curiosity, a little risk tolerance, and maybe a drink in hand. Each week, we break down big-picture events shaping the economy, micro trends impacting specific stocks and sectors, and one or two trades we think are worth exploring—whether it’s a long-term hold or a short-term gamble. This isn’t financial advice—it’s just two degens talking markets, making bets, and trying to stay ahead of the game. Investing is a gamble. Let’s make it a good one.
Episodes

Wednesday Mar 12, 2025
Wednesday Mar 12, 2025
March 11, 2025. Wow, its been a week. Tariffs have thrown the market out of whack and we are trying to find a bottom. Are there deals to be made? Is this a buying moment? Today we talk about DraftKings (DKNG), Celsius (CELH), RInemehtah (RNMBY), and of course, MSTR!. Also, will Brewski talk Ben into buy Rivian? Find out!
Disclaimer: The information provided in this podcast is for general informational purposes only and should not be construed as financial, investment, or trading advice. We are not licensed financial professionals, and the views expressed are solely our own opinions. Always do your own research and consult with a qualified financial advisor before making any investment decisions. Investing in stocks involves risks, and past performance is not indicative of future results. We do not guarantee the accuracy, completeness, or timeliness of the information discussed in each episode.

Wednesday Mar 05, 2025
March 4, 2025 Episode 3 - Tariffs, Bitcoin Bros, and the Smoot-Hawley Act!
Wednesday Mar 05, 2025
Wednesday Mar 05, 2025
March 4, 2025. Its episode 3 and we’re coming right out of Trumps speech to congress. Tariffs have hit and we are trying to make heads or tails of an insane market. As always, we’ve got a lot to talk about including Bitcoin bros, Meta, RocketLabs, Sofi, and Microstrategy. We also go deep into history with the Smoot-Hawley act. Its like school but more fun. Come hang out and listen in to 2 guys trying to make sense of it all. Enjoy!
Disclaimer: The information provided in this podcast is for general informational purposes only and should not be construed as financial, investment, or trading advice. We are not licensed financial professionals, and the views expressed are solely our own opinions. Always do your own research and consult with a qualified financial advisor before making any investment decisions. Investing in stocks involves risks, and past performance is not indicative of future results. We do not guarantee the accuracy, completeness, or timeliness of the information discussed in each episode.

Wednesday Feb 26, 2025
Episode 2 - Februrary 26 2025
Wednesday Feb 26, 2025
Wednesday Feb 26, 2025
We’re back for Episode 2 - and wow it's been a week - so we have a ton to chat about. In today’s episode Ben and Brewksi talk about an amazing Celsius (CELH) trade, Nvidia (NVDA) upcoming earnings, Bitcoin, a TSLA short (yep, we are ready for the hate), and those HIMS earnings. Brewski walks us through his Microstrategy (MSTR) trade and Ben chats through Nike and Kohls. Enjoy!

Friday Feb 21, 2025
Episode 1 - Welcome to Degenerate Capital!
Friday Feb 21, 2025
Friday Feb 21, 2025
Its our first episode! Get to know Ben and Brewski and listen to their yarns of how they got into investing. In this episode we talk about some of our fundamental rules and philosophies of how we navigate the stock market. Got some good stories in this one!
Disclaimer: The information provided in this podcast is for general informational purposes only and should not be construed as financial, investment, or trading advice. We are not licensed financial professionals, and the views expressed are solely our own opinions. Always do your own research and consult with a qualified financial advisor before making any investment decisions. Investing in stocks involves risks, and past performance is not indicative of future results. We do not guarantee the accuracy, completeness, or timeliness of the information discussed in each episode.